Evogene
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,611 | $1,796 | $914 | $4,190 |
Gross Profit | 856 | 715 | -236 | 3,880 |
EBITDA | -2,540 | -4,681 | -5,229 | -3,008 |
EBIT | -3,133 | -5,308 | -5,842 | -3,679 |
Net Income | 427 | -7,630 | -5,419 | -3,863 |
Net Change In Cash | 1,611 | 1,796 | 914 | 4,190 |
Free Cash Flow | -5,529 | -5,060 | -5,486 | -4,251 |
Cash | 15,301 | 11,317 | 9,484 | 11,915 |
Basic Shares | 5,697 | 5,807 | 5,090 | 5,062 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,511 | $5,640 | $1,675 | $930 |
Gross Profit | 5,828 | 1,399 | 766 | 163 |
EBITDA | -15,478 | -23,204 | -26,933 | -27,795 |
EBIT | -17,982 | -25,816 | -29,513 | -30,029 |
Net Income | -16,485 | -23,879 | -26,638 | -27,793 |
Net Change In Cash | 8,511 | 5,640 | 1,675 | 930 |
Free Cash Flow | -20,326 | -22,362 | -24,849 | -25,563 |
Cash | 15,301 | 20,772 | 28,980 | 32,325 |
Basic Shares | 5,697 | 4,568 | 4,121 | 4,043 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.06 |
2024-09-30 | -$1.31 |
2024-06-30 | -$1.06 |
2024-03-31 | -$0.08 |
